Cytocast

Cytocast is a TechBio startup company founded in 2019, headquartered in Hungary. The company's slogan, "Safer and Smarter Drug Development - Transforming drug development and precision medicine with advanced cell simulation," reflects its mission to revolutionize drug development and precision medicine with its Cytocast Digital Twin platform. The platform integrates multi-omics data and advanced computational modeling to predict the effects of different drugs on cellular processes, enabling early-stage drug side effect predictions. Cytocast is at the forefront of advancing personalized medicine, moving towards tailored therapies with its advanced technologies. In May 2023, the company secured a €1.64M investment in a Pre-Seed Round from investors including Bonitas Venture Capital Fund, Zoiros Ventures, FastVentures, Futurmed, and KDT Holding. Cytocast's innovative approach and focus on patient well-being position it as a promising player in the Biotechnology, Health Care, Medical Devices, Pharmaceutical, and Clean Energy industries.